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Abstract 
The objective of this study was to evaluate long-term health-related quality of life outcomes among patients who 
had a colectomy within the previous 10 years. A cross-sectional survey was administered to consecutive patients 
≥18 years of age with ulcerative colitis who had a colectomy within the last 10 years from centers in Canada, Australia, 
and the United Kingdom. Data were extracted from medical chart reviews to confirm selected self-reported patient 
characteristics. Of 351 survey respondents, 49 % were male and the median age was 40 years (interquartile range 
30–52). Respondents were diagnosed with UC a median of 9.2 (5.7–15.1) years prior to the survey and first surgery 
occurred a median of 3.7 (2.1–5.8) years ago. Although most respondents (84 %) reported improved quality of life 
compared to the status before surgery, 81 % experienced problems in at least one of the following areas: depression, 
work productivity, restrictions in diet, body image, and sexual function. According to HADS scores, 30 and 17 % of 
survey respondents experienced anxiety and depression, respectively. Among moderate to severe UC patients pre-
colectomy, 27 % of men and 28 % of women reported that their sexual life was worse now than before surgery. The 
mean EQ-5D utility index score overall was 0.79 (95 % confidence interval 0.77–0.81). Quality of life after colectomy for 
UC is generally good, but there are persistent quality of life issues that impact multiple domains, including psychologi-
cal and sexual functioning.
Keywords: Ulcerative colitis, Colectomy, Survey, Quality of life, pouchitis/pouch failure
© 2015 Brown et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Ulcerative colitis (UC) is an inflammatory bowel disease 
(IBD) characterized by chronically active or recurrent 
episodes of inflammation of the colon. It is estimated to 
affect approximately 0.25 % of the general population in 
the Western world (Gracie and Ford 2012; Molodecky 
et  al. 2012). Signs and symptoms of UC, encompass-
ing rectal bleeding, bloody diarrhea, fecal incontinence, 
abdominal cramps and pain, range from mild to severe 
and can substantially impact health-related quality of life 
(HRQL) (Schreiber et al. 2012). When pharmacological/
biological management of UC has failed or in the context 
of neoplasia, colectomy is indicated. The 10-year risk of 
colectomy following diagnosis of ulcerative colitis is 16 % 
(Frolkis et  al. 2013). The current gold standard surgery 
for UC patients is proctocolectomy with an ileal pouch 
anal anastomosis (IPAA) (Travis et al. 2008).
Although proctocolectomy has many advantages, 
it does have disadvantages, especially with respect to 
clinical and humanistic burden. Post-proctocolectomy 
complications include pouchitis, pouch leakage, pelvic 
abscesses, pouch fistulae, small bowel obstruction, anas-
tomotic stricture, post-operative bleeding, faecal incon-
tinence, sexual dysfunction, infections, delayed wound 
healing, and nerve damage (Frolkis et  al. 2014; de Silva 
et  al. 2011; Dayan and Turner 2012; Kaplan et  al. 2008; 
Hueting et al. 2004, 2005; Lichtenstein et al. 2006).
A retrospective analysis of 666 patients with UC who 
underwent a colectomy reported that 27  % experienced 
severe postoperative complications, with the mortal-
ity rate being 1.5  % (de Silva et  al. 2011). This study 
also highlighted that elderly patients and patients with 
multiple comorbidities are more likely to experience 
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complications. A meta-analysis demonstrated that the 
risk of postoperative mortality is 0.7 % following an elec-
tive operation and 5.3 % following an emergent colectomy 
for UC (Singh et al. 2014). Another meta-analysis showed 
an approximate threefold increase (from 15 to 48  %) in 
the risk of infertility in women with UC as a result of 
IPAA (Waljee et  al. 2006). Johnson et  al. reported the 
infertility rate in females who had pelvic pouch surgery 
was significantly higher as compared to females who 
were managed medically (38.1 % compared with 13.3 %; 
p < 0.001) (Johnson et al. 2004).
Published studies that have evaluated HRQL among 
UC patients after proctocolectomy vary in their conclu-
sions, with some reporting significant improvement and 
others modest or no improvement and with certain nega-
tive long-term consequences (Berndtsson and Oresland 
2003; Fazio et  al. 1999; Martin et  al. 1998; Van Balkom 
et al. 2012; Fazio et al. 2013). A systematic review iden-
tifying 33 studies describing QoL, HRQL and health sta-
tus of UC patients after IPAA found that although HRQL 
and health status were generally improved 12  months 
after proctocolectomy with IPAA, QoL was not reported 
by any study (Heikens et  al. 2012). Given the variability 
in findings across UC QoL studies, it would be useful to 
have a clear understanding of the effects of proctocolec-
tomy with IPAA or ileostomy on patient QoL. Such data 
can help patients and physicians weigh the pros and the 
cons of the surgery and help provide more personalized 
care to these patients. This study was aimed to evaluate 
the long-term health-related quality of life (HRQL) out-
comes of UC patients from Europe, North America, and 
Australia after having a proctocolectomy for UC using a 
variety of survey tools.
Methods
Study design
This study was a cross-sectional survey administered 
online or via paper to patients with UC who had a colec-
tomy within the past 10  years with data collected from 
November 2010 to July 2011 and is referred to as the 
Long-term Outcomes of Colectomy Surgery among 
Ulcerative Colitis Patients Study (LOCUS). For descrip-
tive purposes, this study refers to colectomy and procto-
colectomy collectively as ‘colectomy’.
Study population
The study population consisted of patients treated at 
five centers in Canada, Australia, and the UK. In Can-
ada and Australia, ethics approval was obtained at site-
specific institutional review boards (IRBs). In the UK, 
the study was approved by the National Health Service 
Research and Development Forum (NHS R&D) and 
supported by the National Institute for Health Research 
Comprehensive Clinical Research Network (NIHR 
CCRN). In addition, for UK patients recruited through a 
patient recruitment agency, the study was approved by a 
commercial IRB (MaGil IRB, Rockville, MD, USA).
Patients were included if surgery for UC occurred not 
greater than 10 years prior to entering the study, if they 
were at least 18 years of age and less than 65 years of age 
at the date of colectomy, and if they were fluent in Eng-
lish and willing to provide informed consent. Persons 
were excluded from participating in the study if they had 
Crohn’s disease or colon cancer, abdominal surgery less 
than 2 months prior to the date of screening, or did not 
have competency to provide fully informed consent in 
the screener’s opinion.
Procedures
Consecutive patients who were potentially eligible were 
identified via databases in hospital clinics and in private 
practice settings of both gastroenterologists and colorec-
tal surgeons. Those fulfilling the eligibility criteria were 
recruited by site coordinators who sent study participants 
a web link to complete the survey or mailed the paper 
questionnaire. A medical chart review was performed 
by site coordinators to confirm the diagnosis and date of 
diagnosis of UC, type and date of surgery and reported 
postoperative complications (e.g., pouchitis). This confir-
mation was done to minimize the risk of self-report bias 
and misclassification errors.
This study included the below seven survey tools.
  • Inflammatory Bowel Disease Questionnaire (IBDQ) 
This 32-item questionnaire was used to measure 
bowel symptoms, systemic symptoms, and emotional 
and social functioning with respect to UC. The total 
IBDQ score, which ranges from 32 to 224 with higher 
scores indicating better functioning, was used to 
determine patients’ overall level of functioning (Guy-
att et al. 1989).
  • EQ-5D This health-status utility measure assesses five 
basic life domains (mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression), was used 
to compute utility weights. Utilities are configured 
such that 0.0 is associated with being dead and 1.0 is 
associated with full health; thus, a higher utility value 
is considered better (EuroQol 1990).
  • Body Image Questionnaire (BIQ) This was used to 
assess body image and satisfaction with surgical scar-
ring post-colectomy. Five general body image items 
are scored on a 4-point scale from 1 (“no, not at all”) 
to 4 (“yes, extremely”), and are summed to compute 
a score ranging from 5 to 20, with higher scores indi-
cating poorer body image. The second set of items 
pertain to the colectomy surgical scar, scored on a 
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7-point scale from “very unsatisfied” to “very satis-
fied” or “revolting” to “beautiful”. Body Image Scale 
scores were compared to previously published scores 
of colectomy patients by Polle 2007, Dunker 1998, 
and Larson 2008 (Löwe and Clement 1996).
  • Medical Outcomes Study Sexual Functioning Scale 
(MOS-SFS) This 4-item measure of sexual function-
ing from the RAND Corporation’s Medical Out-
comes Study (MOS) has been used in a variety of 
patient populations and the general US population. 
Higher scores indicate worse sexual functioning. A 
“do not wish to answer” option was added for this 
study (patients who did not wish to answer were 
treated as missing in the analysis) (Tarlov et al. 1989).
  • Hospital Anxiety and Depression Scale (HADS) This 
14-item self-report measure designed to assess levels 
of anxiety and depression was used to measure gen-
eral levels of mood symptomatology. Subscale scores 
for anxiety and depression range from 0 to 21 with 
lower scores indicating fewer mood-related symp-
toms. A cut-off of 7/8 is used to classify mild inten-
sity and a cut-off of 10/11 is used to classify severe 
intensity for the anxiety and depression subscales 
(Zigmond and Snaith 1983).
  • Dietary Restrictions Questions This survey included 
three questions related to dietary restrictions, each of 
which was analyzed separately.
  • WHO Work Performance Questionnaire—Absentee-
ism and Presenteeism (WHO-HPQ-AP) This is a set 
of seven items that measures work performance by 
examining normal working schedule, missed work 
due to health-related difficulties, scheduled time 
off work (i.e., non-health related missed work), and 
general level of job performance. Better work perfor-
mance is indicated by low levels of absenteeism and 
high levels of presenteeism (Kessler et al. 2003).
The proportions of LOCUS participants who reported 
detriments in the HRQL domains of mood (i.e. depres-
sion), work productivity, diet (i.e. greater eating restric-
tions), sexual life, body image, and ongoing need for 
medication for bowel condition were evaluated and 
reported.
Analyses
Descriptive statistics, including mean scores and propor-
tions, were calculated for the items and scales, as appli-
cable. The IBDQ, EQ-5D, MOS-SFS, WHO-HPQ, and 
HADS were scored according to scoring instructions 
of the developer. EQ-5D scores were calculated using 
UK weights. Selected item-level and scale scores were 
compared using Wilcoxon–Mann–Whitney test or Chi 
square, as applicable. All comparisons were tested using 
two-tailed tests at α = 0.05. All analyses were performed 
using SAS Enterprise Guide Version 4.3 (Cary, NC, USA).
Results
Study population
The surveys were sent to 743 eligible patients who met 
the inclusion criteria and 424 patients (57  %) returned 
the surveys. However, 73 patients were excluded from 
analysis because of incomplete key information for pri-
mary objectives in the questionnaire (Fig. 1). Thus, a total 
of 351 patients with complete surveys were included in 
the analysis, including 126 in Canada, 126 in the UK, 
and 99 in Australia. Demographics and clinical char-
acteristics are presented in Table  1. Of survey respond-
ents (n = 351) 49 % were male and the median age was 
40  years (interquartile range 30–52). Respondents were 
diagnosed with UC a median of 9.2 (5.7–15.1) years prior 
to the survey and first surgery occurred a median of 3.7 
(2.1–5.8) years ago. The majority of respondents reported 
moderate to severe UC prior to surgery. Approximately 
one-third (32 %) had a stoma at some time after the crea-
tion of the ileal pouch and 36  % reported a history of 
pouch complications.
Quality of life and satisfaction with colectomy
The majority of respondents (305, 87  %) reported that 
they were “somewhat satisfied”, “satisfied”, or “very satis-
fied” with colectomy. Most (294, 84 %) also reported an 
improvement in their quality of life post-surgery, with 
46  % stating that their current quality of life was “very 
improved.”
The results of the various survey tools applied are 
shown in Table 2. The median IBDQ score was 172 (inter-
quartile range 147–190), with clinical remission generally 
scoring above 170. The mean EQ-5D index score was 
0.79 (95 % CI 0.77–0.81) and the mean EQ-5D VAS score 
was 77.0 (95 % CI 75.3–78.6).
HADS scores identified 30  % of respondents with 
clinically meaningful anxiety, and 17  % with clinically 
meaningful depression (scores ≥8 on the anxiety and 
depression scales indicate the presence of the condi-
tion). Women were nearly twice as likely to have clinically 
meaningful anxiety as men (39.8 vs. 21.1  %, p  <  0.001) 
(Fig.  2). There was no significant difference in clinically 
meaningful depression scores between male and female 
patients (18.6 vs. 14.5  %, p =  0.30) (Fig.  2). The results 
also showed that patients without full-time employment 
were more likely to have clinically meaningful anxiety 
and depression than full-time employed patients (anxi-
ety 39.1 vs. 21.4 %, p < 0.001; depression 23.8 vs. 8.9 %, 
p < 0.001) (Fig. 3).
In response to the BIQ items, 21–34 % of respondents 
reported that colectomy led to “quite a bit” or “extreme” 
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negative impacts and 34 % reported at least some dissat-
isfaction with their surgical scar. Body image scale scores 
were worse among women than men (p  <  0.0001) and 
worse among those <50 years of age (p < 0.05).
MOS-SFS scores varied widely among surveyed UC 
patients (Table 2). Women reported scores on average 11 
points worse than did men. Among moderate to severe 
UC patients pre-colectomy (n = 330), 27 % of men and 
Fig. 1 Flowchart of the Patients who were included in the statistical analysis
Table 1 Demographics and clinical characteristics of participants
 Characteristic All Australia Canada United Kingdom
Participants, n (%) 351 99 (28 %) 126 (36 %) 126 (36 %)
Gender, n (%)
 Male 173 (49 %) 50 (51 %) 59 (47 %) 64 (51 %)
 Female 178 (51 %) 49 (49 %) 67 (53 %) 62 (49 %)
Age (years), median (IQR) 40 (30–52) 42 (33–53) 40 (29–52) 38 (31–49)
Years since first surgery, median (IQR) 3.7 (2.1–5.8) 3.4 (1.4–5.5) 3.8 (2.4–5.5) 4.1 (2.4–6.8)
Years since diagnosis, median (IQR) 9.2 (5.7–15.1) 10.5 (5.4–17.5) 8.8 (5.7–15.7) 9.2 (6.3–13.3)
UC severity prior to surgery, n (%)
 Mild 21 (6 %) 8 (8 %) 8 (6 %) 8 (4 %)
 Moderate 50 (14 %) 15 (15 %) 11 (9 %) 24 (19 %)
 Severe 280 (80 %) 76 (77 %) 107 (85 %) 97 (77 %)
Number of surgical procedures, n (%)
 2 228 (65 %) 70 (20 %) 100 (28 %) 58 (17 %)
 3 90 (26 %) 22 (6 %) 36 (10 %) 32 (9 %)
 4 14 (4 %) 5 (1 %) 3 (1 %) 6 (2 %)
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28 % of women reported that their sexual life was worse 
now than before surgery (Table  3). While only 48 of 
respondents had tried to conceive since surgery, women 
were more likely to report having trouble conceiving than 
men (64 vs. 22 %) (Table 3).
Of all respondents, 68 % were employed either full- or 
part-time, and 8 % were students. When asked about their 
current productivity compared to before surgery, moder-
ate to severe patients (n = 312) reported a mean of 3.4 on 
the WHO Work Performance Questionnaire of survey 
respondents, corresponding to “slightly more productive”. 
However, among LOCUS participants with moderate to 
severe UC prior to surgery, 33 % reported decreased work 
productivity post-colectomy (Table  4). Overall, respond-
ents reported a mean of 1  day missed from work over 
the past month due to health reasons, corresponding to 
approximately 12 days per year on average. A mean score 
of 4.2, on a scale from 0 to 10, was reported for how UC 
had affected the ability to perform daily activities (other 
than work or school) in the past month.
Of the respondents overall, 19  % said that their diet 
interferes with their daily life “moderately” or “very 
much”, and 19 % said that they are “moderately” or “very” 
bothered by the dietary impacts resulting from their sur-
gery for UC. The majority (59 %) of patients with moder-
ate to severe UC prior to surgery experienced the same or 
more eating restrictions after surgery compared to pre-
colectomy (Table 4).
The majority of patients (79 %, 177/224) with an ileal 
pouch reported improved or stable stool frequency 
after surgery (Table  4). Although, 46  % (n  =  160) of 
study respondents reported taking medication currently 
for gastrointestinal conditions, of which the majority 
(61  %) took medications to regulate bowel movements 
(Table 5).
LOCUS respondents reported detriments in the HRQL 
domains of mood (i.e., depression) (17 %), work produc-
tivity (33 %), diet (i.e., greater eating restrictions) (34 %), 
sexual life (29 %), body image (29 %), and ongoing need 
for medication for bowel condition (46 %) (Fig. 4).
Discussion
Among patients with UC, life after proctocolectomy 
and IPAA is generally reported to lead to a measurably 
improved HRQL. While postoperative mortality is low 
and early post-operative complications have been care-
fully documented, long term effects on various aspects 
of HRQL have received less systematic attention. Such 
knowledge supports therapeutic decision-making for 
both the doctor and patient. The study attempted to bet-
ter define such effects by using multiple validated survey 
tools in a large population of patients with colectomy and 
either an IPAA or ileostomy (Additional file 1: Table S1 to 
Table S5).
Not unexpectedly, the majority (84 %) of patients with 
UC reported an improved HRQL after surgery, as most 
had poorly controlled disease as the indication for sur-
gery. However, the majority of patients experienced 
impairments in HRQL in the years following surgery 
with eight out of ten experiencing detriments in at least 
one HRQL domain, specifically depression, body image, 
greater eating restrictions, sexual function, productiv-
ity, or ongoing need for medication for bowel condition. 
A previous study from one institution reported 87  % of 
103 UC patients who underwent colectomy were satisfied 
with the procedure, but 93 % experienced some kind of 
functional restriction in work, social, physical, or sexual 
life after surgery (Rokke et  al. 2011). The current study 
showed that such impairments were common regardless 
of institution or nationality.
Table 2 Survey and  scale results of  LOCUS participants 
(n = 351)
a Moderate to severe UC patients only
b 1 = much more productive, 7 = much less productive
c Impact of bowel condition on daily activities (other than work/school) in the 
past month (0–10 scale; 0 = “my condition had no effect on my daily activities”, 
10 = “my condition completely prevented me from doing my daily activities”
Survey Score: median (IQR),  
mean ± SD or proportion: n (%)




 Utility 0.79 ± 0.2
 Visual analog scale 77.0 ± 16.1
Hospital anxiety and depression scale (anxiety scores)
 None (<8) 241 (69 %)
 Mild (8–10) 54 (15 %)
 Severe (11–21) 52 (15 %)
 Missing 4 (1 %)
Hospital anxiety and depression scale (depression scores)
 None (<8) 291 (83 %)
 Mild (8–10) 38 (11 %)
 Severe (11–21) 20 (6 %)
 Missing 2 (1 %)
Body image scale 9 (7–13)
 Male 8 (6–11)
 Female 11 (8–14)
 Age group ≥50 years 8 (6–11)
 Age group <50 years 10 (7–13)
Medical outcomes study sexual functioning scale
 Male 8.3 (0–41.7)
 Female 19.4 (0–58.3)
Work productivitya,b 3.4 ± 2.0 “slightly more productive”
Daily Activitya,c 4.2 ± 2.6





























Rates of Anxiety and Depression 
Male (n=171 for anxiety evaluaon; n=172 for depression evaluaon)
Female (n=176 for anxiety evaluaon; n=177 for depression evaluaon)
*4 paents were excluded due to missing values in anxiety evaluaon and 2 paents were excluded 
due to missing values in depression evaluaon. 





























Rates of Anxiety and Depression 
Full me employed (n=168 for anxiety evaluaon; n=168 for depression evaluaon)
Non full-me employed (n=179 for anxiety evaluaon; n=181 for depression evaluaon)
*4 paents were excluded due to missing values in anxiety evaluaon and 2 paents were excluded 
due to missing values in depression evaluaon. 
Fig. 3 Proportion of LOCUS respondents with anxiety and depression between full-time employed and non-full-time employed patients*
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About one-third of participants with moderate to 
severe UC prior to colectomy with IPAA reported they 
had the same or increased stool frequency after surgery. 
Additionally, nearly one half of all survey respondents 
reported taking medications to regulate bowel move-
ments. While all patients had been cured of UC, many 
patients still scored poorly on the IBDQ, with a score less 
than the generally-accepted cut-off value representing 
‘good’ (>170), as previously described (Lichtenstein et al. 
2006; Haapamäki et al. 2009; Meyer et al. 2009; Watanabe 
et al. 2006).
Overall HRQL is considered a more important meas-
urement of wellbeing after major surgery than any 
individual symptom score. The EQ-5D is a survey tool 
demonstrated to have validity for generalizing health sta-
tus among the general population, persons with different 
diseases, and across many different countries (Rabin and 
de Charro 2001; Stark et al. 2010). The EQ-5D has been 
applied to populations of patients with UC who have not 
had surgical resection in Germany and Australia. Mean 
EQ-5D index scores were 0.91 and 0.71 in the German 
cohort and 0.81 and 0.72 in an Australian cohort for 
patients with inactive and active disease, respectively 
(Gibson et al. 2013; Yoshida et al. 2014). Furthermore, in 
the Australian study, mild disease was associated with a 
mean EQ-5D score of 0.78 and moderate to severe dis-
ease 0.68. In our study, patients with UC post-colectomy 
reported a mean EQ-5D score of 0.79, suggesting good 
overall HRQL, but similar to UC patients with mild dis-
ease (Stark et al. 2010).
Among LOCUS participants, nearly one in three 
reported anxiety and one in six reported depression 
according to the HADS. Depression and anxiety were 
both more common among those who reported less than 
full-time employment. These data may reflect that the 
employment status of the patient may have an impact on 
the patient’s mood, and provides a potential target for 
interventional strategies to address in patients with UC 
post-colectomy.
Approximately one-third of LOCUS participants 
reported “quite a bit” and “extreme” negative impacts 
on body image post-colectomy. Not surprisingly, one in 
three patients had at least some dissatisfaction with the 
abdominal scar, as most patients had an open laparotomy. 
One of the key advantages of laparoscopic colectomy and 
pouch formation is the cosmetic advantage and minimi-
zation of wound-related complications such as incisional 
hernia. It is unlikely, however, that this was a major drive 
of reduced quality of life. The impact on sexual func-
tion was a more likely candidate. Sexual functioning 
Table 3 Fertility questions by  gender among  participants 
with moderate to severe ulcerative colitis prior to surgery 
(N = 330)
Having mild disease prior to surgery is largely uncharacteristic of the pre-
colectomy UC population, as colectomy is typically indicated for moderate to 
severe UC, and thus those patients were excluded from the selected analyses 
that specifically compared pre- and post-colectomy
a Of patients who tried to conceive children
Males Females
Characteristic N = 161 N = 169
How has your sexual life changed compared to before surgery?
 Better 27 (17 %) 43 (25 %)
 Same 69 (43 %) 42 (25 %)
 Worse 44 (27 %) 47 (28 %)
 Not applicable or do not wish to answer 21 (13 %) 37 (22 %)
Since surgery
 I have tried to conceive or have biological 
children
23 (14 %) 25 (15 %)
 I have had difficulties conceiving since my 
surgerya
5/23 (22 %) 16/25 (64 %)
Number of children
 None 64 (40 %) 72 (43 %)
 1–3 90 (56 %) 72 (54 %)
 4 or more 6 (4 %) 4 (2 %)
 Do not wish to answer 1 (1 %) 1 (1 %)
Table 4 Report of  work productivity, eating restrictions, 
and  stool frequency among  participants with  moderate 
to severe ulcerative colitis prior to surgery (N = 330)
Having mild disease prior to surgery is largely uncharacteristic of the pre-
colectomy UC population, as colectomy is typically indicated for moderate to 
severe UC, and thus those patients were excluded from the selected analyses 
that specifically compared pre- and post-colectomy
a Only patients with an ileal pouch (n = 224, 68 %)
Characteristic N %
Has your work productivity changed compared to before surgery?
 No change 49 15
 Slightly more to much more productive 163 49
 Slightly less to much less productive 108 33
 Missing 10 3
Have your eating restrictions changed compared to before surgery?
 Fewer 127 39
 Same 87 26
 More 110 33
 Missing 6 2
Has your stool frequency changed compared to before surgery?a
 Fewer 157 70
 Same 20 9
 More 45 20
 Missing 2 1
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was significantly impacted among UC patients post-
colectomy, with more than 25 % of men and women with 
moderate to severe UC prior to colectomy reporting a 
worse sexual life after surgery. This is higher than the rate 
reported from a single centre study conducted in Nor-
way, in which 17 % of study participants reported a worse 
sexual life post-colectomy (Rokke et  al. 2011), although 
the instruments used to measure such function were 
not the same. Other studies have reported higher rates 
of worse sexual function among UC/IBD patients after 
surgery (Yoshida et  al. 2014; Muller et  al. 2010). Only 
14 % of men and 15 % of women of LOCUS participants 
with moderate to severe UC prior to surgery had tried to 
conceive, possibly a reflection of voluntary childlessness 
previously noted in patients with IBD (Marri et al. 2007), 
and they described trouble conceiving, with women 
being more affected.
The findings of this study are also critical for health 
care payers who strive to achieve cost-effectiveness. Even 
though surgery may be a cheaper option to pursue for 
these patients, in the era of personalized care and the 
increased role of patients in disease management and 
decision-making, the need for surgery should be evalu-
ated on an individual patient basis. Surgery may not be 
an acceptable or preferred option for all patients. In their 
study, to quantify the preferences for treatment options 
among UC patients, gastroenterologists, and colorec-
tal surgeons, Byrne et al. reported that 89 % of patients, 
69  % of gastroenterologists, and 55  % of colorectal sur-
geons were more prepared to gamble or trade part of 
their life expectancy to avoid any surgery (Byrne et  al. 
2014). Bewtra et al. also reported that patients with UC 
were willing to accept relatively high risk of dying from 
medical therapy in order to avoid a permanent ostomy 
(Bewtra et al. 2014). For certain patients, such as patients 
who have psychological problems, emotional instability, 
poor motivation or who are non-compliant, the psycho-
logical impact of surgical intervention could be immense 
(Frizelle and Burt 2001). Our study showed that about 
one-third of participants reported same or increased 
Table 5 Medication usage for gastrointestinal conditions after surgery among participants
Medication usage reported among LOCUS Participants (N = 160) %
Medications to regulate bowel movements (loperamide, codeine) 99/160 (61 %)
Antibiotics (ciprofloxacin, metronidazole) 23/160 (14 %)
Immune-modulating agents (thiopurines, anti-TNF monoclonal antibodies, methotrexate) 9/160 (6 %)
Aminosalicylates 7/160 (4 %)
Proton pump inhibitors 5/160 (3 %)
Analgesics (fentanyl, acetaminophen, gabapentin) 5/160 (3 %)
Supplements (iron, B12, probiotics) 4/160 (3 %)
Antispasmodics (anti-cholinergics) 4/160 (2 %)
Steroids (rectal steroids, prednisone) 3/160 (2 %)






































Detriments in HRQL domains 
Fig. 4 Proportion of LOCUS respondents with detriments in health-related quality of life (HRQL) domains
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stool frequency after surgery. In addition, almost one half 
of all survey respondents reported taking medications 
to regulate bowel movements. These concerns should 
also be taken in account, given their significant impact 
on a patient’s lifestyle and HRQL. In addition, patients 
with ulcerative proctitis may receive reduced or delayed 
benefits from surgery compared with those with more 
extensively-located disease. Therefore, surgery is rarely 
indicated for this population, while infliximab has shown 
efficacy in bringing clinical response in patients with 
ulcerative proctitis (Whitlow 2004; Bouguen et al. 2010). 
Colectomy may thus not be a “one size fits all” solution.
The use of biologics has been recommended by the 
European Crohn’s and Colitis Organization (ECCO) 
guidelines and current literature suggests that some of 
the biologics reduce the need for colectomy (Dignass 
et  al. 2012; Lopez et  al. 2015). The use of biologics has 
also been recommended by the NICE guidelines, “with 
the choice of treatment between biologics be made on an 
individual basis after discussion between the responsible 
clinician and the patient about the advantages and disad-
vantages of the treatments available” (National Institute 
for Health and Care Excellence 2015).
The strengths of this study include the array of HRQL 
domains assessed, which allows for a more comprehen-
sive assessment of HRQL than is currently available in 
the literature. Further, our recruitment across multiple 
centers in three countries makes the findings more gen-
eralizable to a majority of colectomy patients and mean-
ingful to patients considering colectomy. In addition, 
patient-reported data were supplemented with medi-
cal chart data, which helped to validate and interpret 
patient-reported data. This study adds to the literature by 
providing patient-reported information regarding overall 
HRQL and satisfaction with colectomy.
The data should be interpreted in the context of the 
study limitations. First, pre-colectomy data were limited 
to that recorded in the medical chart. Secondly, the study 
population was captured after surgery and comparison 
of HRQL measures pre- and post-surgery was not pos-
sible. And we do not have a control population that did 
not undergo the surgery. Thus, the data can only be used 
to characterize the current status of the study popula-
tion and provide comparison data with that published 
in the literature. Thirdly, the response rate was 57 % and, 
therefore, the findings may be subject to a non-response 
bias. For example, patients who had extreme perceptions 
of their surgery (e.g., highly improved or considerably 
worse off) may have selectively agreed to participate in 
the study. Fourthly, while validated HRQL measures were 
used, the data are predominantly based on self-reported 
information from the patients, and no physician assess-
ment was used to validate the responses. However, this 
was somewhat minimized by cross-checking of key 
information by medical chart review, which would have 
minimized errors associated with, for example, misclas-
sification of diagnosis and surgery.
In conclusion, HRQL is good but not great for UC 
patients following colectomy, as impairments were found 
in multiple domains using a variety of assessment tools. 
While surgical intervention can be lifesaving in many UC 
patients, induction of medical remission and avoidance of 
surgery altogether is still the ideal. The data derived from 
this study provide important information for rational 
decision-making between physicians and patients, so that 
the need for surgery may be evaluated on an individual 
patient basis.
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